ANXA2 and neoplasm: It has been shown that sub-cutaneous inoculation of plasminogen negative tumour cells (LLC) in plasminogen-null mice produced tumors only 10-35% smaller compared to control mice [38], while we observed a 70-85% decrease in tumor volume in the A549 and HT1080 ANXA2 depleted tumors compared to control tumors.